2-Bromo-TMA, or 2-Br-TMA, also known as 2-bromo-3,4,5-trimethoxyamphetamine, is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA). It is the 2-brominated derivative of TMA. The drug's dose is approximately 200mg orally and its duration is approximately 8hours. Compared to TMA, 2-bromo-TMA is described as being only slightly less potent, being more active in altering visual perception, and having fewer physical side effects in comparison. 2-Bromo-TMA was described in the scientific literature by Daniel Trachsel and colleagues in 2013, who cited personal communication with P. Rausch in 2009 for the information. It is a controlled substance in Canada as an analogue of Amphetamine.
See also 3C (psychedelics) 2-Bromomescaline DODB 2C-DB Bromotomscaline Bromojimscaline TeMA (2-methoxy-TMA) Methyl-TMA
References
External links 2-Br-TMA - Isomer Design Novel Psychedelic Mescaline Analog 2-Bromo-3,4,5-trimethoxyamphetamine (2-Br-TMA, BTMA); A Collection of Bioassays - /r/researchchemicals - Reddit 2-CI-TMA (2-CTMA) & 2-I-TMA (2-ITMA); A Collection of Bioassavs - Bluelight